SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Advantest Corporation (ADTTF) trades at a trailing P/E of 0.7, forward P/E of 0.3. Trailing earnings yield is 142.86%, forward earnings yield 303.03%. PEG 0.02 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (0.7); PEG ≤ 1.0 — Peter Lynch undervalued (0.02); earnings yield beats bond yields (142.86%).
- Forward P/E 0.3 (down from trailing 0.7) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 142.86% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 303.03% as earnings recover.
Overall SharesGrow Score: 93/100 with 6/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — ADTTF
Valuation Multiples
P/E (TTM)0.7
Forward P/E0.3
PEG Ratio0.02
Forward PEG0.02
P/B Ratio0.00
P/S Ratio0.14
EV/EBITDA0.0
Per Share Data
EPS (TTM)$218.01
Forward EPS (Est.)$463.16
Book Value / Share$0.00
Revenue / Share$1,054.64
FCF / Share$0.00
Yields & Fair Value
Earnings Yield142.86%
Forward Earnings Yield303.03%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$35.38 |
$162.11B |
$6.69B |
4.1% |
| 2016 |
$73.95 |
$155.92B |
$14.2B |
9.1% |
| 2017 |
$92.04 |
$207.22B |
$18.1B |
8.7% |
| 2018 |
$286.99 |
$282.46B |
$56.99B |
20.2% |
| 2019 |
$67.24 |
$275.89B |
$53.53B |
19.4% |
| 2020 |
$87.96 |
$312.79B |
$69.79B |
22.3% |
| 2021 |
$111.82 |
$416.9B |
$87.3B |
20.9% |
| 2022 |
$173.67 |
$560.19B |
$130.4B |
23.3% |
| 2023 |
$84.16 |
$486.51B |
$62.29B |
12.8% |
| 2024 |
$218.01 |
$779.71B |
$161.18B |
20.7% |
